A citation-based method for searching scientific literature

Jialing Huang, Li-Hui Tseng, Vamsi Parini, Parvez M Lokhandwala, Aparna Pallavajjala, Erika Rodriguez, Rena Xian, Liam Chen, Christopher D Gocke, James R Eshleman, Ming-Tseh Lin. Am J Clin Pathol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
Patrick S Ward, Jay Patel, David R Wise, Omar Abdel-Wahab, Bryson D Bennett, Hilary A Coller, Justin R Cross, Valeria R Fantin, Cyrus V Hedvat, Alexander E Perl,[...]. Cancer Cell 2010
50

Liver resection and transplantation for intrahepatic cholangiocarcinoma.
Vincenzo Mazzaferro, Andre Gorgen, Sasan Roayaie, Michele Droz Dit Busset, Gonzalo Sapisochin. J Hepatol 2020
64
50

Ferroptosis: an iron-dependent form of nonapoptotic cell death.
Scott J Dixon, Kathryn M Lemberg, Michael R Lamprecht, Rachid Skouta, Eleina M Zaitsev, Caroline E Gleason, Darpan N Patel, Andras J Bauer, Alexandra M Cantley, Wan Seok Yang,[...]. Cell 2012
50

Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism.
Li Su, Xinglong Zhang, Lei Zheng, Miaomiao Wang, Zhifa Zhu, Ping Li. Front Endocrinol (Lausanne) 2020
4
50

Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
Julia Delahousse, Loic Verlingue, Sophie Broutin, Clémence Legoupil, Mehdi Touat, Ludovic Doucet, Samy Ammari, Ludovic Lacroix, Michel Ducreux, Jean-Yves Scoazec,[...]. Eur J Cancer 2018
21
50

The implications of IDH mutations for cancer development and therapy.
Christopher J Pirozzi, Hai Yan. Nat Rev Clin Oncol 2021
32
50

HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRASQ61L cells.
Fanghua Ye, Wenwen Chai, Min Xie, Minghua Yang, Yan Yu, Lizhi Cao, Liangchun Yang. Am J Cancer Res 2019
57
50

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy.
Zi-Jian Zhang, Yun-Peng Huang, Xiao-Xue Li, Zhong-Tao Liu, Kai Liu, Xiao-Feng Deng, Li Xiong, Heng Zou, Yu Wen. Front Oncol 2021
3
50

Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways.
Jaroon Wandee, Piyarat Srinontong, Auemduan Prawan, Laddawan Senggunprai, Sarinya Kongpetch, Chavi Yenjai, Veerapol Kukongviriyapan. Naunyn Schmiedebergs Arch Pharmacol 2021
3
50

Usefulness of bile as a biomarker via ferroptosis and cysteine prenylation in cholangiocarcinoma; role of diagnosis and differentiation from benign biliary disease.
Jin-Yi Han, Keun Soo Ahn, Won-Ki Baek, Seong-Il Suh, Yong Hoon Kim, Tae-Seok Kim, Koo Jeong Kang. Surg Oncol 2020
4
50

Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma.
Margaret A Hill, William B Alexander, Bing Guo, Yasutaka Kato, Krushna Patra, Michael R O'Dell, Matthew N McCall, Christa L Whitney-Miller, Nabeel Bardeesy, Aram F Hezel. Cancer Res 2018
49
50

LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells.
Wenchuan Qi, Zhenhua Li, Longjiang Xia, Jiangshan Dai, Qiao Zhang, Chuanfang Wu, Si Xu. Sci Rep 2019
71
50

IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC.
Jian Wang, Zhan-Guo Zhang, Ze-Yang Ding, Wei Dong, Hui-Fang Liang, Liang Chu, Bi-Xiang Zhang, Xiao-Ping Chen. J Surg Res 2018
6
50

Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS.
Detian Yuan, Shan Huang, Emanuel Berger, Lei Liu, Nina Gross, Florian Heinzmann, Marc Ringelhan, Tracy O Connor, Mira Stadler, Michael Meister,[...]. Cancer Cell 2017
92
50

Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
Xinghan Wu, Chuanliang Liu, Zihaoran Li, Chengcheng Gai, Dejun Ding, Weijuan Chen, Fengyun Hao, Wentong Li. Mol Cell Biochem 2020
23
50

Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.
Sunisa Thongsom, Wipa Suginta, Kyung Jin Lee, Han Choe, Chutima Talabnin. Apoptosis 2017
47
50

Quercetin induces p53-independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species-dependent ferroptosis.
Zi-Xuan Wang, Jing Ma, Xin-Yu Li, Yong Wu, Huan Shi, Yao Chen, Guang Lu, Han-Ming Shen, Guo-Dong Lu, Jing Zhou. Br J Pharmacol 2021
28
50

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.
Whitney B Pope, Robert M Prins, M Albert Thomas, Rajakumar Nagarajan, Katharine E Yen, Mark A Bittinger, Noriko Salamon, Arthur P Chou, William H Yong, Horacio Soto,[...]. J Neurooncol 2012
210
50


The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis.
Tian-Xiang Wang, Jun-Yun Liang, Cheng Zhang, Yue Xiong, Kun-Liang Guan, Hai-Xin Yuan. Cell Death Dis 2019
17
50

Ferroptosis at the crossroads of infection, aging and cancer.
Shinya Toyokuni, Izumi Yanatori, Yingyi Kong, Hao Zheng, Yashiro Motooka, Li Jiang. Cancer Sci 2020
35
50

Ferroptosis Inhibition: Mechanisms and Opportunities.
Jose Pedro Friedmann Angeli, Ron Shah, Derek A Pratt, Marcus Conrad. Trends Pharmacol Sci 2017
222
50

Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy.
Shunqin Zhu, Qin Yu, Chunsong Huo, Yuanpeng Li, Linshen He, Botian Ran, Ji Chen, Yonghao Li, Wanhong Liu. Curr Med Chem 2021
28
50

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
50



Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Al B Benson, Alan P Venook, Lynette Cederquist, Emily Chan, Yi-Jen Chen, Harry S Cooper, Dustin Deming, Paul F Engstrom, Peter C Enzinger, Alessandro Fichera,[...]. J Natl Compr Canc Netw 2017
480
50

Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making.
David R Gandara, Primo N Lara, Philip Mack, Giorgio Scagliotti. Clin Lung Cancer 2009
21
50

The long tail of oncogenic drivers in prostate cancer.
Joshua Armenia, Stephanie A M Wankowicz, David Liu, Jianjiong Gao, Ritika Kundra, Ed Reznik, Walid K Chatila, Debyani Chakravarty, G Celine Han, Ilsa Coleman,[...]. Nat Genet 2018
397
50

Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
Amir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, Nana Mensah, Ivelise Rijo, Snjezana Dogan, JinYuan Yao, Christine Moung, Chad Vanderbilt, Jamal Benhamida,[...]. J Mol Diagn 2021
6
50

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A Shukla, Zhi Rong Qian, Ofir Cohen, Reiko Nishihara, Samira Bahl, Yin Cao, Ali Amin-Mansour, Mai Yamauchi,[...]. Cell Rep 2016
422
50

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T Chang, Andy Ni, Ritika Kundra, Philip Jonsson,[...]. Cancer Discov 2017
318
50

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Mercedes Delgado-García, Birgit Weynand, Lourdes Gómez-Izquierdo, María José Hernández, Ángela María Blanco, Mar Varela, Xavier Matias-Guiu, Ernest Nadal, Bélgica Márquez-Lobo, Ana Alarcão,[...]. BMC Cancer 2020
8
50

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
518
50

Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.
Matthias Van Haele, Sara Vander Borght, An Ceulemans, Michiel Wieërs, Sofie Metsu, Xavier Sagaert, Birgit Weynand. J Clin Pathol 2020
19
50

Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.
Konrad H Stopsack, Subhiksha Nandakumar, Kanika Arora, Bastien Nguyen, Samantha E Vasselman, Barbara Nweji, Sean M McBride, Michael J Morris, Dana E Rathkopf, Susan F Slovin,[...]. Clin Cancer Res 2022
5
50

Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal Cancer.
Gregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, Michael J Babcock, Kristi Mitchell, Yi Ding, Lisa Scicchitano, Adrian Tira, Lela Buckingham, Sara Atkinson,[...]. Am J Clin Pathol 2020
5
50

Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Kelly L Bolton, Ryan N Ptashkin, Teng Gao, Lior Braunstein, Sean M Devlin, Daniel Kelly, Minal Patel, Antonin Berthon, Aijazuddin Syed, Mariko Yabe,[...]. Nat Genet 2020
122
50

Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
Laetitia Lambros, Charline Caumont, Briac Guibourg, Fanny Barel, Isabelle Quintin-Roué, Pascale Marcorelles, Jean-Philippe Merlio, Arnaud Uguen. J Clin Pathol 2017
32
50

KRAS mutations: an old oncogene becomes a new predictive biomarker.
Gregory J Riely, Marc Ladanyi. J Mol Diagn 2008
40
50

The landscape of genomic alterations across childhood cancers.
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, Ivo Buchhalter, Kortine Kleinheinz, Vasilisa A Rudneva, Pascal D Johann, Gnana Prakash Balasubramanian, Maia Segura-Wang, Sebastian Brabetz,[...]. Nature 2018
580
50

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.
Philip Jonsson, Andrew L Lin, Robert J Young, Natalie M DiStefano, David M Hyman, Bob T Li, Michael F Berger, Ahmet Zehir, Marc Ladanyi, David B Solit,[...]. Clin Cancer Res 2019
52
50

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.
Wassim Abida, Joshua Armenia, Anuradha Gopalan, Ryan Brennan, Michael Walsh, David Barron, Daniel Danila, Dana Rathkopf, Michael Morris, Susan Slovin,[...]. JCO Precis Oncol 2017
213
50

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.
Yongliang Zhang, Yu Yao, Yaping Xu, Lifeng Li, Yan Gong, Kai Zhang, Meng Zhang, Yanfang Guan, Lianpeng Chang, Xuefeng Xia,[...]. Nat Commun 2021
29
50


Non-coding recurrent mutations in chronic lymphocytic leukaemia.
Xose S Puente, Silvia Beà, Rafael Valdés-Mas, Neus Villamor, Jesús Gutiérrez-Abril, José I Martín-Subero, Marta Munar, Carlota Rubio-Pérez, Pedro Jares, Marta Aymerich,[...]. Nature 2015
540
50

Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Solène M Evrard, Estelle Taranchon-Clermont, Isabelle Rouquette, Samuel Murray, Sebastian Dintner, Yun-Chung Nam-Apostolopoulos, Beatriz Bellosillo, Mar Varela-Rodriguez, Ernest Nadal, Klaus H Wiedorn,[...]. J Mol Diagn 2019
24
50

BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
Brunangelo Falini, Maria Paola Martelli, Enrico Tiacci. Blood 2016
51
50

NCCN Guidelines Insights: Melanoma, Version 3.2016.
Daniel G Coit, John A Thompson, Alain Algazi, Robert Andtbacka, Christopher K Bichakjian, William E Carson, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming,[...]. J Natl Compr Canc Netw 2016
63
50

Mutations driving CLL and their evolution in progression and relapse.
Dan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart, Johannes G Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Bozic, Mike Lawrence, Sebastian Böttcher,[...]. Nature 2015
615
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.